As an example, in prostate cancer, the transfer of pyruvate kinase 2 from the primary tumor to bone marrow stromal cells results in the increased expression of CXCL12 in the bone marrow in an HIF1α-dependent manner, favoring the establishment of metastatic cells in bone [109]. The gene discussed is CXCL12; the disease is neoplasm.